More on PCSA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (8.0 Score)

Upcoming Events

- Earnings (2/9/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Processa Pharmaceuticals Inc. (NQ:PCSA)
Delayed: 2.08 +0.23 (12.43%)
Prev. Close $1.85  
Open$1.90 
52 Wk High$ 
52 Wk Low$ 
Day High$2.12 
Day Low$1.90 
P/E N/A  
EPS$ 
Volume39,354 

Friends, Peers and Foes (?): SXTP AENT (more...)

Sep 1, 2026 07:00 AM Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
Aug 18, 2026 05:00 PM Form SCHEDULE 13G Processa Pharmaceuticals Filed by: Soleus Capital Master Fund, L.P.
Aug 14, 2026 04:13 PM Form 10-Q Processa Pharmaceuticals For: Jun 30
Aug 11, 2026 04:22 PM Form 4 Processa Pharmaceuticals For: Aug 08 Filed by: Ng George K
Aug 4, 2026 05:26 PM Form 8-K Processa Pharmaceuticals For: Jul 30
Jul 30, 2026 09:50 PM Form 4 Processa Pharmaceuticals For: Jul 28 Filed by: GUJRATHI SHEILA
Jul 30, 2026 09:46 PM Form 3 Processa Pharmaceuticals For: Jul 28 Filed by: GUJRATHI SHEILA
Jul 29, 2026 07:36 AM Form 8-K Processa Pharmaceuticals For: Jul 23
Jul 29, 2026 07:30 AM Processa acquires Vidya Therapeutics in $200M private placement deal
Jul 29, 2026 07:30 AM PROCESSA PHARMACEUTICALS, INC. ANNOUNCES ACQUISITION OF VIDYA THERAPEUTICS, INC. AND APPROXIMATELY $200 MILLION CONCURRENT PRIVATE PLACEMENT TO ADVANCE BTK INHIBITOR, VT-7208, IN MULTIPLE DISEASE AREA
View All Articles

Entities mentioned with PCSA

View All Entities